Ganirelix 0.25mg


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Female infertility Orgalutran 0.25mg Injection prevents release of premature eggs during a process called ovulation in females. This helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy. It is given as an injection by a doctor or nurse and should not be self-administered. You should use the medicine as prescribed for it to be effective.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
In females undergoing treatment for infertility, sometimes premature ovulation can lead to the release of those eggs which are not ready for fertilization. Orgalutran 0.25mg Injection blocks the action of a natural hormone and prevents premature release of the eggs from the ovary.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Orgalutran 0.25mg Injection .
Not Safe: Orgalutran 0.25mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Not Safe: Orgalutran 0.25mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Seek medical advice from your doctor: It is not known whether Orgalutran 0.25mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Caution Advised: Orgalutran 0.25mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Orgalutran 0.25mg Injection may be needed. Doctor consultation is advised. Use of Orgalutran 0.25mg Injection is not advised in patients with moderate to severe kidney disease patients.
Caution Advised: Orgalutran 0.25mg Injection should be used with caution in patients with liver disease. Dose adjustment of Orgalutran 0.25mg Injection may be needed. Doctor consultation is advised. Use of Orgalutran 0.25mg Injection is not advised in patients with moderate to severe liver disease patients.
Gala No-1C, Bldg No. -B3, City Link Warehouse Com, Mumbai Nashik Highway,Vadapa, Tal Bhiwandi, Distt Thane 421 302
Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 655
EMEA. Ganirelix (03 Apr. 2019)
Ganirelix. Ravensburg, Germany: Vetter Pharma-Fertigung GmbH & Co (03 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.